For the treatment of respiratory diseases and upper respiratory tract now increasingly used anti-inflammatory drugs, including Erespal. Contra-indications for its use are limited, since the drug is not toxic. However, the need to take account of these contraindications.

Features action Erespal

Erespal inflammatory effect (active substance - fenspiride) due to the fact that it inhibits the action of a number of biologically active substances which are involved in inflammatory and allergic reactions, as well as bronchospasm. In addition, Erespal has inflammatory properties (removes the increased tone of smooth muscles of the bronchi) and may have already begun to take bronchospasm. Erespal deduced mainly with urine, but also partly in the faeces.

Available Erespal pharmaceutical company Servier Laboratories (France) in the form of tablets, coated tablets, syrup and oral. Auxiliaries Erespal tablets are calcium hydrogenphosphate, hypromellose, povidone, colloidal anhydrous silica, magnesium stearate. Tablets are coated, which comprises titanium dioxide, glycerol, hypromellose, Macrogol 6000, and magnesium stearate.

In Erespal syrup contains the following excipients: flavoring composition with honey smell, licorice, vanilla tincture, glycerol, dye "sunset yellow" (Sunset yellow S), methyl parahydroxybenzoate, propyl parahydroxybenzoate, saccharin, sucrose, potassium sorbate, purified water.

For each of the formulations has its indications and contraindications for use.

Contraindications to the use of the dosage form in the form of tablets

Tablets Erespal used only for the treatment of adults. This is due to the fact that the testing of this formulation on children and adolescents have not been conducted. For children and adolescents under 18 years of applied Erespal other dosage forms - syrup.

Tablets are contraindicated Erespal also in case of hypersensitivity of the patient to the components of this drug. Not recommended Erespal during pregnancy and nursing Breastfeeding - a personal choice   breast, as finally established whether this drug causes any harm to the woman or the fetus. However, the use of Erespal during pregnancy is not a reason for the interruption.

Typically, such wording in the instructions to drugs say that in the course of its manufacture were carried out only laboratory research on animals that showed no teratogenic or mutagenic effects of the drug. Clinical trials Erespal in pregnant women have not been conducted and therefore no one will dare to recommend its use during pregnancy. It does not set well, whether it is allocated Erespal breast milk and what effect it may have on the body of the baby.

Research on the impact of Erespal Erespal - a cure for allergies and inflammation   the central nervous system have not been conducted, however, we know that this drug may cause drowsiness, decreased concentration and light incoordination, so combine its welcome with driving is not recommended. Nor should combine reception Erespal tablets with taking sedatives (tranquilizers) or sleeping pills and alcohol.

Contraindications for the use of the dosage form in the form of a syrup for oral administration

Syrup for oral Erespal is used to treat adults and children from two years. It is also contraindicated in hypersensitive to the components of the drug by the body of the patient, during pregnancy and breastfeeding.

With the composition of the syrup Erespal include sucrose, so it is prescribed with caution in patients with intolerance to some simple sugars (eg, fructose) malabsorption of glucose Glucose: The energy source   or galactose in the small intestine (malabsorption syndrome), some deficiency of digestive enzymes that contribute to the splitting of simple sugars (sucrase, isomaltase). The presence of syrup Erespal simple sugars is also an obstacle to the appointment of the drug to patients with diabetes Diabetes - threatening and incurable disease . But sometimes syrup Erespal diabetics still prescribe (if it is vital), while increasing the dose of antidiabetic agents.

Precautions syrup Erespal administered in allergic diseases (especially in the presence of allergy to aspirin), as dye Sunset Yellow S, included in its composition, may cause allergic reactions, including bronchospasm.

Galina Romanenko

Today, the treatment of acute and chronic inflammatory airway increasingly prescribed Erespal. The use of this drug not only reduces the duration of acute disease, but also prevents its transition to a chronic inflammatory process. A chronic respiratory diseases Erespal treats and prevents recurrence.

Application Erespal for treatment of acute lung disease

Acute bacterial, viral, allergic or toxic processes in bronchopulmonary system are accompanied by inflammation in the walls of the bronchial tubes. If this inflammation is significantly patency of the bronchi will be broken. And this in turn slows down the healing process and contributes to its transition into a chronic disease.

That is why today in the complex treatment of acute inflammatory bronchopulmonary system, both adults and children include anti-inflammatory drugs, including Erespal. Erespal suppresses the production of biologically active substances promoting the development of inflammation and allergies (allergic and inflammatory mediators), resulting in reduced inflammation, bronchial tubes become more passable. Furthermore, Erespal inhibits the production of inflammatory fluid, and hence has a positive effect on the formation of phlegm, making it less viscous.

Simultaneously Erespal suppresses spasm of bronchial smooth muscle, and if he has already appeared, contributes to its withdrawal and the widening of the bronchi (bronchodilator effect). Reduction of inflammation in combination with antibacterial treatment, expectorant and liquefies phlegm drugs promotes rapid healing and prevents the transition of acute inflammation in chronic.

Application Erespal for the treatment of chronic lung disease

Erespal often included in the comprehensive treatment of chronic bronchopulmonary diseases. Very often it is prescribed for chronic obstructive pulmonary disease - COPD.

According to modern representations of complex treatment of patients with COPD should provide for adequate treatment of the underlying disease, smoking cessation, systematic anti-inflammatory and bronchodilator therapy. The structure of such a complex treatment of COPD today often included Erespal possessing anti-inflammatory, a bronchodilator, normalizing education and the influence of the viscosity of sputum. Erespal COPD prescribed long, sometimes for a period of six months to a year or more. This leads to long-term suppression of inflammation in bronchi, bronchial wall edema and pulmonary tissue.

The inclusion of complex treatment of patients with COPD Erespal contributes to a significant improvement of the patients and confirmed by additional research. They have reduced the signs of respiratory distress, increased exercise tolerance, reduced the number of relapses.

Application Erespal for the treatment of bronchial asthma

In bronchial asthma Bronchial asthma - the body's response inadequate   the introduction of the comprehensive treatment Erespal Erespal - a cure for allergies and inflammation   It helps reduce the duration of the clinical manifestations of disease, cough and bronchospasm, reduces the period of restoration of patency of the bronchi. Improved patency of the bronchi, in turn, contributes to a better oxygenation of arterial blood, preventing inflammation in the respiratory system and cardiac events.

Application Erespal for the treatment of diseases of ENT organs

Any inflammatory diseases of the upper respiratory tract are accompanied by edema Prevention and treatment of edema - it is important to understand the root cause   mucous membranes, which greatly complicates their treatment. Therefore, the treatment of such diseases (primarily sinusitis - inflammation of the sinuses) are trying to reduce inflammation and swelling. For example, in the treatment of sinusitis Sinusitis - the treatment may only be carried out under the supervision of a physician   swelling violates drainage and ventilation of the maxillary sinuses. This leads to stagnation of inflammatory secretions in the sinuses and the transition simple (serous) purulent inflammation in the development of complications, including on the part of the brain.

Application Erespal in this case, reduces inflammation, swelling, promotes free flow of sinus inflammation and fluid access to it of air, and this in turn is a prerequisite for recovery.

Erespal - a modern anti-inflammatory drug, has an effect in the respiratory tract and upper respiratory tract, which also has antispasmodic and anti-allergy properties.

Galina Romanenko